In pancreatic cancer, ALKBH5-mediated upregulation of DDIT4-AS1 maintains pancreatic cancer stemness and inhibits chemosensitivity through activation of the mTOR pathway (35). Here, DDIT4 is linked to pancreatic neoplasm.